Requirements for different pharmaceutical forms or dosages [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2020-07-13 13:52 (99 d 19:14 ago) – Posting: # 21683
Views: 501

Dear, what is the guideline from EMA that I would found the bioavailability requirements for different pharmaceutical forms or dosages?
For example, comparing tablet vs suspension (with same dosage), extende release vs immediate release, tablet 500 mg vs tablet 250 mg (with same drug).

Thank you for any help!

Complete thread:

 Admin contact
21,170 posts in 4,411 threads, 1,474 registered users;
online 5 (0 registered, 5 guests [including 1 identified bots]).
Forum time: Wednesday 09:06 CEST (Europe/Vienna)

But it is in matters beyond the limits of mere rule
that the skill of the analyst is evinced.
He makes in silence a host of observations and inferences…    Edgar Allan Poe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz